Tawfeg Ben-Omran
FRCPC, MBCHB
Division Chief
Years of Experience: 27
Dr. Tawfeg Ben-Omran is the Division Chief of Genetics and Genomic Medicine at Sidra Medicine, a women’s and children’s hospital in the State of Qatar.
Dr. Ben-Omran’s clinic provides comprehensive genetic and metabolic services including clinical evaluation and risk assessment; genetic counselling; diagnosis and the advanced management for a variety of genetic and metabolic disorders in pediatric patients of all ages. The clinic also offers ongoing multidisciplinary care for patients with genetic and metabolic conditions and support them access resources and treatment programs personalized to their condition.
The clinic also offers genetic counselling in partnership with the Qatar National Premarital Genetic Screening Program. Other key services include preimplantation genetic testing (PGT) and prenatal genetic testing and diagnosis. As well as managing positive Inborn Errors of Metabolism identified through the National Expanded Metabolic Newborn Screening Program.
Read more
- Arabic
- English
- Medical degree from Al Arab Medical University in Libya and his residency in clinical and metabolic genetics from the Hospital of Sick Children in Canada.
- Fellow of the Royal College of Physicians and Surgeons of Canada; the Canadian College of Medical Genetics and is also a corresponding fellow from the American College of Medical Genetics and Genomics.
- Professor at Weill-Cornell Medicine, Qatar
- Distinguished visiting scientist at Boston Children’s Hospital in the USA.
- Member of Hamad Medical Corporation’s National Newborn Screening Committee and National Premarital Genetic Screening program.
- Clinical and Metabolic Genetics.
- Gene Therapy
- Genomic medicine
- Inborn errors of metabolism
- Genetic counselling
- Gene therapy for spinal muscular atrophy: the Qatari experience
- Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.
- Expanding on the phenotypic spectrum of Woodhouse-Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review.
Clinics & Services
Doctor's News
Our Insurance Partners
Our Insurance Partners
